Benjamin F. Edwards & Company’s Imunon IMNN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	1847
2022 Q1	$0	Buy	+1	New	+$78	﹤0.01%	1788

Other funds holding IMNN

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Benjamin F. Edwards & Company's IMNN Position: Q2 2022 in Review

Benjamin F. Edwards & Company sold out of Imunon (IMNN) in Q2 2022, closing a stake of 1 share.

Benjamin F. Edwards & Company first reported a position in IMNN in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 24 funds tracked by Wall St. Rank hold IMNN as of Q2 2022.

Benjamin F. Edwards & Company reported no remaining Imunon position as of Q2 2022 after selling out during the quarter.
Benjamin F. Edwards & Company sold 1 Imunon share in Q2 2022.
Benjamin F. Edwards & Company first reported a position in Imunon in Q1 2022 and held it in 1 quarter.
Benjamin F. Edwards & Company's Imunon position peaked at $0 in Q1 2022.
24 funds tracked by Wall St. Rank held Imunon as of Q2 2022.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2022, filed 12 Aug 2022.